SC

Subhash Chandra

Active Director Director DIN 11913127
DIN 11913127 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhash Chandra

Subhash Chandra is a Director at Kamdgiri Pharmaceutical Private Limited (since 2026).

DIN 11913127
Primary Designation Director
First Appointment 25 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20262026Active

Board colleagues of Subhash Chandra

NameDINCompanyDesignation
Lav Kumar Yadav11913128Kamdgiri Pharmaceutical Private LimitedDirector/Designated Partner
Satya Bhooshan Dube11913129Kamdgiri Pharmaceutical Private LimitedDirector
Sudha SahuKamdgiri Pharmaceutical Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Kamdgiri Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Subhash Chandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chandra

Subhash Chandra currently holds 1 directorship: Kamdgiri Pharmaceutical Private Limited (Director, since 25 Aug 2026).

Subhash Chandra was first appointed on 25 Aug 2026 as Director at Kamdgiri Pharmaceutical Private Limited.

The current boards of Subhash Chandra's companies include Lav Kumar Yadav (Kamdgiri Pharmaceutical Private Limited), Satya Bhooshan Dube (Kamdgiri Pharmaceutical Private Limited), Sudha Sahu (Kamdgiri Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available